- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ExpreS2ion Biotech Holding AB (EXPRS2)
ExpreS2ion Biotech Holding AB stock price live, this page displays ST EXPRS2 stock exchange data. View the EXPRS2 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ExpreS2ion Biotech Holding AB real time stock price chart below.
What Is the ExpreS2ion Biotech Holding AB Stock Price Today?
The ExpreS2ion Biotech Holding AB stock price today is 24.00.
What Is the Stock Symbol for ExpreS2ion Biotech Holding AB?
The stock symbol for ExpreS2ion Biotech Holding AB is "EXPRS2."
What Stock Exchange Does ExpreS2ion Biotech Holding AB Trade On?
ExpreS2ion Biotech Holding AB is listed and trades on the Stockholm stock exchange.
Is ExpreS2ion Biotech Holding AB a Good Stock to Buy?
Determining whether ExpreS2ion Biotech Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXPRS2 quote. (ISIN: SE0023261292)
What Is the ExpreS2ion Biotech Holding AB Stock Price Today?
The ExpreS2ion Biotech Holding AB stock price today is 24.00.
What Is the Stock Symbol for ExpreS2ion Biotech Holding AB?
The stock symbol for ExpreS2ion Biotech Holding AB is "EXPRS2."
What Stock Exchange Does ExpreS2ion Biotech Holding AB Trade On?
ExpreS2ion Biotech Holding AB is listed and trades on the Stockholm stock exchange.
Is ExpreS2ion Biotech Holding AB a Good Stock to Buy?
Determining whether ExpreS2ion Biotech Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXPRS2 quote. (ISIN: SE0023261292)
Stockholm
Currency in SEK
24.00
+1.00(+4.35%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.40
24.00
52 wk Range
0.81
37.60
EXPRS2 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 12 days
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.4024.00
52 wk Range
0.8137.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EXPRS2 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
303.00
Upside
+1,162.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
ExpreS2ion Biotech Company Profile
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally. The company’s lead asset is ES2B-C001, a therapeutic vaccine for breast cancer that targets the human epidermal growth factor receptor 2 receptor. It is also developing ES2B-I002, a cytomegalovirus vaccine candidate to treat infectious diseases. In addition, the company out licenses its ExpreS2 platform to research institutes and pharmaceutical companies. Further, it sells ExpreS2 test kits and reagents for research purposes or diagnostic applications. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria; and Evaxion Biotech A/S for development of cytomegalovirus vaccine, as well as partnership agreement with Copenhagen University to develop vaccine for Influenza. The company operates an online store. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.
Compare EXPRS2 to Peers and Sector
Metrics to compare | EXPRS2 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEXPRS2PeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −1.6x | −0.6x | |
PEG Ratio | −0.02 | −0.04 | 0.00 | |
Price/Book | 0.7x | 2.1x | 2.6x | |
Price / LTM Sales | 6.1x | 10.3x | 3.1x | |
Upside (Analyst Target) | - | 109.0% | 51.3% | |
Fair Value Upside | Unlock | 15.1% | 7.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 303.00
(+1,162.50% Upside)
Earnings
Latest Release
Nov 29, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the ExpreS2ion Biotech (EXPRS2) Stock Price Today?
The ExpreS2ion Biotech stock price today is 24.00.
What Stock Exchange Does ExpreS2ion Biotech Trade On?
ExpreS2ion Biotech is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for ExpreS2ion Biotech?
The stock symbol for ExpreS2ion Biotech is "EXPRS2."
What Is the ExpreS2ion Biotech Market Cap?
As of today, ExpreS2ion Biotech market cap is 50.41M.
What is ExpreS2ion Biotech Earnings Per Share?
The ExpreS2ion Biotech EPS is -23.33.
What Is the Next ExpreS2ion Biotech Earnings Date?
ExpreS2ion Biotech will release its next earnings report on 05 Feb 2025.
From a Technical Analysis Perspective, Is EXPRS2 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.